Can Buying CERo Therapeutics Holdings Inc. (NASDAQ: CERO) Still Be Worthwhile?

CERo Therapeutics Holdings Inc. (NASDAQ:CERO) does about 5.41M shares in volume on a normal day but saw 2430528 shares change hands in the recent trading day. The company now has a market cap of 5.12M USD. Its current market price is $0.10, marking a decrease of -5.04% compared to the previous close of $0.11. The 52 week high reached by this stock is $12.80 whilst the lowest price level in 52 weeks is $0.10.

CERo Therapeutics Holdings Inc. (CERO) has a 20-day trading average at $0.1339 and the current price is -99.22% off the 52-week high compared with -1.67% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.1729 and its 200-day simple moving average is $3.8528. If we look at the stock’s price movements over the week, volatility stands at 14.32%, which decreases to 11.01% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 28.46 to suggest the stock is oversold.

The current price level is -26.65%, -43.62%, and -97.45% away from its SMA20, SMA50, and SMA200 respectively, with the CERO price moving above the 50-day SMA on current market day. CERo Therapeutics Holdings Inc. (CERO) stock is down -21.54% over the week and -29.22% over the past month. Its price is -99.09% year-to-date and -99.08% over the past year.

Outstanding shares total 51.35M with insiders holding 12.55% of the shares and institutional holders owning 9.05% of the company’s common stock. The company has a return on investment of -682.23% and return on equity of -4090.08%. The beta has a value of -0.38.